GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cartesian Therapeutics Inc (FRA:1S70) » Definitions » Policy Acquisition Expense

Cartesian Therapeutics (FRA:1S70) Policy Acquisition Expense


View and export this data going back to 2016. Start your Free Trial

What is Cartesian Therapeutics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Cartesian Therapeutics Business Description

Traded in Other Exchanges
Address
704 Quince Orchard Road, Gaithersburg, MD, USA, 20878
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.